On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayAug 25, 2016 2:24 pm

Versartis, Inc. (VSAR) Completes Enrollment in Phase III VELOCITY Trial of Somavaratan for the Treatment of Pediatric GHD

In a recent news release, Versartis, Inc. (NASDAQ: VSAR), an endocrine-focused biopharmaceutical company, announced the completion of enrollment for its phase III VELOCITY trial of somavaratan, a long-acting form of recombinant human growth hormone (rhGH) currently being evaluated for the treatment of pediatric growth hormone deficiency (GHD). The randomized, open-label registration trial will focus on pre-pubertal children with GHD who are naïve to treatment. Moving forward, the 137 enrolled patients will be followed for the primary trial endpoint of height velocity at 12 months, along with safety and pharmacodynamics secondary endpoints. Versartis expects to present top-line results from the VELOCITY…

Continue Reading

ThursdayAug 25, 2016 1:06 pm

eXp World Holdings’ (EXPI) Agent-Owned Cloud Brokerage Offers a New Deal as New Home Sales Keep Rising

eXp World Holdings, Inc. (OTCQB: EXPI) is offering Americans a 21st century new deal with its Agent-Owned Cloud Brokerage™. Back in the 1930s, Americans were, as they have been in recent times, picking up the pieces after a series of devastating economic events, but if we thought the Great Recession was bad, it’s because most of us haven’t been around long enough to remember the Great Depression. Writing in the Wall Street Journal (http://nnw.fm/Diys5), well-known financial commentator and hedge fund director Roger Lowenstein opined that ‘the world didn’t experience anything close to a global depression during the recent crisis. Peak…

Continue Reading

ThursdayAug 25, 2016 12:33 pm

Pluristem Therapeutics, Inc. (PSTI) Secures $8 Million EU Grant for Critical Limb Ischemia Study

Pluristem Therapeutics, Inc. (NASDAQ: PSTI), a leading Israel-based developer of placenta cell therapies for various ailments including ischemia, inflammation, radiation damage and hematology disorders, recently secured an $8 million grant from the European Union for its critical limb ischemia (CLI) program, according to a news release (http://nnw.fm/YvNo5) issued August 9. The CLI grant, offered under the EU’s largest research and innovation program, Horizon 2020, will cover a significant portion of Pluristem’s PLacental eXpanded (PLX) PAD cells study, which will enroll about 250 U.S. and European patients suffering from CLI Rutherford Category 5. This category of patients is commonly unsuitable for…

Continue Reading

WednesdayAug 24, 2016 3:57 pm

Dynasil Corporation of America (DYSL) Subsidiary Receives $1.86 Million in Grants from U.S. Department of Energy

In a recent news release, Dynasil Corporation of America (NASDAQ: DYSL) announced that RMD, Inc., its contract research subsidiary, has been awarded two phase II grants totaling $1.86 million under the U.S. Department of Energy’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. The SBIR program is designed to help domestic small businesses explore their technological potential by encouraging them to engage in federal research and development that has the potential for commercialization, while the STTR program aims to bridge the gap between performance of basic science and commercialization of resulting innovations. Funding stemming from the…

Continue Reading

WednesdayAug 24, 2016 2:30 pm

Medical Transcription Billing Corp. (MTBC) (MTBCP) Full-Spectrum Web EHR & Services Platform Poised to Pop as Healthcare IT Market Booms

A recent report (http://nnw.fm/K8iRV) on the global Healthcare IT (HIT) market from Technavio projects an attractive seven percent CAGR for the space over the next four years, when the U.S. sector alone will generate upwards of $75 billion annually. The analysts at MarketsandMarkets affirmed this outlook in their report on the sector late last year (http://nnw.fm/UO9j8), projecting that the global healthcare IT market will see a CAGR nearly twice the Technavio figure when all sources are accounted for, coming to represent a total market valued at somewhere in the neighborhood of $228 billion by 2020. The biggest names in the…

Continue Reading

WednesdayAug 24, 2016 1:28 pm

eXp World Holdings, Inc. (EXPI) Subject of Updated Research Report by Fundamental Research Corp.

Yesterday, Fundamental Research Corp., an independent research firm specializing in the small-cap and microcap sectors, announced the release of an updated analysis on eXp World Holdings, Inc. (OTCQB: EXPI). The new analysis, which includes upward revisions from Fundamental Research Corp.’s original report released in April of this year, highlights EXPI’s strong fiscal performance in the second quarter of 2016, healthy balance sheet and recent independent additions to its board of directors as reasons prospective investors may want to take a second look at the company. “We are raising our revenue forecast for 2016 from $40.50 million to $48.94 million, and…

Continue Reading

WednesdayAug 24, 2016 9:37 am

Monaker Group, Inc. (MKGI) Set to Expand Industry Partnerships with Launch of Monaker Booking Engine

Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced completion of the design, architecture and buildout of its Application Program Interface (“API”) and the corresponding launch of its Monaker Booking Engine (“MBE”). This announcement marks a key milestone in the company’s efforts to develop a sustainable foothold in the rapidly growing alternative lodging space, as the completed API and MBE will allow Monaker to work toward partnering with large, established online travel agencies, tour operators, airlines and cruise originators to offer its sizable inventory in a real-time booking format. This real-time booking format is key to the company’s future…

Continue Reading

TuesdayAug 23, 2016 1:31 pm

Viacom, Inc. (VIA) Parts Ways with President and CEO following Agreement with National Amusements, Inc.

In a recent news release, Viacom, Inc. (NASDAQ: VIA; VIAB) announced an agreement with National Amusements, Inc. (“NAI”), a privately-owned American theater company and member of the Redstone media empire, settling all disputes between the two parties. Per the terms of the settlement, which has been unanimously approved by the boards of both companies, all outstanding lawsuits between them will be terminated. Additionally, Viacom has agreed to expand its board of directors to include five additional directors elected in June by NAI, including Kenneth Lerer, Thomas May, Judith McHale, Ron Nelson and Nicole Seligman. Moving forward, Seligman will head the…

Continue Reading

TuesdayAug 23, 2016 12:37 pm

Greek Blank Check Company Stellar Acquisition III (STLRU) Announces $65 Million IPO

On Friday, August 19, Stellar Acquisition III, Inc. (NASDAQ: STLRU), a Greece-based blank check company, also commonly referred to as a special purpose acquisition company, announced an initial public offering of $65 million, accounting for 6.5 million units at $10 each. One unit consists of one company share and one warrant allowing the holder to purchase common stock at $11.50 per share. The company had initially planned to offer eight million shares at $10 each, but reconsidered earlier last week. The new IPO is expected to raise up to 19% less than anticipated previously, according to a Renaissance Capital report…

Continue Reading

MondayAug 22, 2016 1:27 pm

CIFC LLC (CIFC) to be Acquired by F.A.B. Partners for $333 Million

On Friday August 19, 2016, CIFC Asset Management (NASDAQ: CIFC), a large U.S. private debt investment manager, and F.A.B. Partners, an alternative investment platform, announced that F.A.B. will acquire CIFC for approximately $333 million in cash. The transaction, which is subject to approval by the shareholders of CIFC and regulators, is expected to be completed by year’s end. The merger comes just months before the new risk retention rules for collateralized loan obligations (“CLOs”) under Dodd-Frank take effect on December 24, 2016. The new rules require CLO managers to purchase and retain five percent of the fair value of any…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217